While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...

Minimally invasive technology enables earlier detection and faster treatment of lung cancer Broward Health Medical Center announced the acquisition of the Ion™ Endoluminal System. This ...

bioAffinity Technologies Inc. BIAF shares are down during Thursday’s premarket session. Over the last week, the stock has surged by more than 100%, as per Benzinga Pro data. The recent momentum ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

When Dan Hannon, 72, received guidance to have part of a lung taken out whether nodules were cancerous or not, he wanted a second opinion to see if he would indeed live the rest of his life without a ...

I heard it in several settings from family medicine clinic to a thoracic surgery operating room, from different levels of the healthcare hierarchy including attending physicians, nurses, technicians, ...

SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new clinical case study. The study highlights the benefits of adding CyPath Lung to ...

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...